302 related articles for article (PubMed ID: 4249468)
21. [Disseminated intravascular coagulation].
Amir J
Harefuah; 1972 Jul; 83(1):29-32. PubMed ID: 4264530
[No Abstract] [Full Text] [Related]
22. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
Miyatani K; Fukui I
Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
[No Abstract] [Full Text] [Related]
23. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator. 4. Antifibrinolytic action of sex hormones, especially a conjugated estrogen (Premarin) and its application.
Mori N; Takemoto J
Acta Obstet Gynaecol Jpn; 1969 Jul; 16(3):137-42. PubMed ID: 4309742
[No Abstract] [Full Text] [Related]
24. Inhibitory effect of normal and cancerous tissues of the bladder on plasminogen activation.
Hisazumi H
Invest Urol; 1973 Nov; 11(3):258-62. PubMed ID: 4270696
[No Abstract] [Full Text] [Related]
25. The activator time. A method for control of activator activity during thrombolytic therapy.
Blix S
Scand J Haematol; 1969; 6(4):221-6. PubMed ID: 5388562
[No Abstract] [Full Text] [Related]
26. Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin.
Camiolo SM; Thorsen S; Astrup T
Proc Soc Exp Biol Med; 1971 Oct; 138(1):277-80. PubMed ID: 5125527
[No Abstract] [Full Text] [Related]
27. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
Weiss AS; Gallin JI; Kaplan AP
J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
[TBL] [Abstract][Full Text] [Related]
28. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
Landmann H
Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
[No Abstract] [Full Text] [Related]
29. The fibrinolytic enzyme system in obesity: the effects of venous occlusion and in vitro activation by surface contact.
Grace CS
Clin Sci; 1968 Jun; 34(3):497-504. PubMed ID: 5666878
[No Abstract] [Full Text] [Related]
30. Recent progress in fibrinolysis.
Mannucci PM; Minetti D; Mari D
Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):328-35. PubMed ID: 160079
[No Abstract] [Full Text] [Related]
31. [The fibrinolytic activity in Seegers' cattle prothrombin preparations. A contribution to the problem of the activation of cattle prothrombin by plasmin].
Andrassy K; Egbring R; Egli H
Thromb Diath Haemorrh; 1969 Nov; 22(2):377-90. PubMed ID: 4245334
[No Abstract] [Full Text] [Related]
32. A method to correct for the continuing activation during the second stage in a two-stage assay. Exemplified by urokinase activation of plasminogen determined by the lysis time method.
Berg W
Thromb Diath Haemorrh; 1968 Mar; 19(1):161-8. PubMed ID: 4231459
[No Abstract] [Full Text] [Related]
33. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
[No Abstract] [Full Text] [Related]
34. Inhibition of thrombin, plasmin and plasminogen activation by amidino compounds.
Geratz JD
Thromb Diath Haemorrh; 1970 Jun; 23(3):486-99. PubMed ID: 4247029
[No Abstract] [Full Text] [Related]
35. Effect of fibrinolysis on adhesion and aggregation of human platelets.
Cronberg S
Thromb Diath Haemorrh; 1968 Jul; 19(3):474-82. PubMed ID: 4236822
[No Abstract] [Full Text] [Related]
36. Measurement during fibrinolytic therapy.
McNicol GP
Proc R Soc Med; 1969 Nov; 62(11 Part 1):1131-3. PubMed ID: 5356869
[No Abstract] [Full Text] [Related]
37. THE ASSESSMENT OF FIBRINOLYTIC ACTIVITY IN THE BLOOD.
FLUTE PT
Br Med Bull; 1964 Sep; 20():195-9. PubMed ID: 14209758
[No Abstract] [Full Text] [Related]
38. Effects of collagen on fibrinolysis.
Engel AM; Alexander B
Thromb Diath Haemorrh Suppl; 1973; 56():63-74. PubMed ID: 4376277
[No Abstract] [Full Text] [Related]
39. [The effect of lysozyme, ribonuclease and cytochrome C on the activation of one of the blood coagulation factors--the Hageman factor--by adrenaline].
Zubairov DM; Popova LG; Akhmetshina MKh
Ukr Biokhim Zh; 1973; 45(1):86-90. PubMed ID: 4348882
[No Abstract] [Full Text] [Related]
40. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
